{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:25:58Z","timestamp":1792787158787,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.amjcard.2026.02.043","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:38:33Z","timestamp":1772177913000},"page":"99-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Association of GLP-1 Receptor Agonist and SGLT2 Inhibitor With Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement"],"prefix":"10.1016","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6248-4353","authenticated-orcid":false,"given":"Alan M.","family":"Fahoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louie","family":"Kamel-Abusalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Didier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Wunderly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Sarrouj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochell","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Afifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2026.02.043_bib0001","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1001\/jama.2024.16477","article-title":"Calcific aortic stenosis: a review","volume":"332","author":"Otto","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1003233","article-title":"Global burden of calcific aortic valve disease and attributable risk factors from 1990 to 2019","volume":"9","author":"Yu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0003","article-title":"Long-term outcomes of transcatheter vs surgical aortic valve replacement: meta-analysis of randomized trials","volume":"3","author":"Talanas","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0004","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.jacc.2018.08.2146","article-title":"5-year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients","volume":"72","author":"Gleason","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102478","article-title":"Complications in transcatheter aortic valve replacement: a comprehensive analysis and management strategies","volume":"49","author":"Zou","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0006","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0007","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0008","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"The Lancet"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0009","first-page":"116","volume":"3","author":"Team","year":"2000"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0010","series-title":"Integrated development for R Version 4.2. 3 [Software]","article-title":"R Studio","year":"2023"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0011","series-title":"Getting started with ggplot2 ggplot2: Elegant Graphics for Data Analysis","first-page":"11","author":"Wickham","year":"2016"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0012","series-title":"Package \u2018tidyr\u2019, Easily Tidy Data With \u2019Spread\u2019 and \u2019Gather","author":"Wickham","year":"2017"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0013","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12933-024-02504-8","article-title":"SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI)","volume":"23","author":"Paolisso","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008681","article-title":"Relative costs of surgical and transcatheter aortic valve replacement and medical therapy","volume":"13","author":"Goldsweig","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0015","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa2500366","article-title":"Dapagliflozin in patients undergoing transcatheter aortic-valve implantation","volume":"392","author":"Raposeiras-Roubin","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0016","article-title":"OR3-24 | Impact of Glp-1 receptor agonists on clinical outcome in non-diabetic obese patients with non-rheumatic aortic stenosis undergoing transcatheter aortic valve replacement","volume":"4","author":"Godbless Ajenaghughrure","year":"2025","journal-title":"JSCAI"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0017","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.amjcard.2022.07.012","article-title":"Benefits of adding glucagon-like peptide 1 receptor agonists to sodium-glucose co-transporter 2 inhibitors in diabetic patients with atherosclerotic disease and heart failure","volume":"181","author":"Lopez","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2024.101594","article-title":"Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies","volume":"51","author":"Scheen","year":"2025","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100927","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers after transcatheter aortic valve replacement: a meta-analysis","volume":"3","author":"Bhat","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0020","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0021","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3390\/ijms23031678","article-title":"SGLT2 inhibitors and their antiarrhythmic properties","volume":"23","author":"Kolesnik","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0022","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12933-024-02312-0","article-title":"The potential anti-arrhythmic effect of SGLT2 inhibitors","volume":"23","author":"Duan","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0023","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.119.042375","article-title":"Effect of empagliflozin on left ventricular mass in patients with type 2 diabetes mellitus and coronary artery disease: the EMPA-HEART CardioLink-6 Randomized Clinical Trial","volume":"140","author":"Verma","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1422740","article-title":"Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects","volume":"15","author":"Riemma","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.043_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1535134","article-title":"Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective","volume":"12","author":"Turkistani","year":"2025","journal-title":"Front Cardiovasc Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926000871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926000871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:48:48Z","timestamp":1775656128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914926000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":26,"alternative-id":["S0002914926000871"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.02.043","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of GLP-1 Receptor Agonist and SGLT2 Inhibitor With Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.02.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}